Sarah A. Kagan presents Strafford webinar, “Blocking Patents: Impact of Acorda Therapeutics on Obviousness Analysis”
Ms. Kagan and her co-presenters, Mark Kachner, partner at Knobbe Martens, and Kevin E. Noonan, partner at McDonnell Boehnen Hulbert & Berghoff, will discuss the expanded doctrine of blocking patents. They will examine the Acorda decision and secondary considerations. They will also address how the decision impacts the obviousness analyses, licensing, and invalidity/validity/opposition searches.
Click here to register or for more information.
